Shield Therapeutics to Attend Biotechnology Industry Organization (BIO)-Europe® 2013

LONDON, October 23, 2013 /PRNewswire/ --

Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that Richard Jones, Chief Financial Officer, and Angela Hildreth, Group Financial Controller, will attend BIO-Europe®2013 which takes place on Monday 4th to Wednesday 6th November in Vienna, Austria.

Help employers find you! Check out all the jobs and post your resume.